Olivier Tredan, MD PhD

Centre Leon Berard
Lyon, Rhone-Alpes, France

Disclosure information not submitted.

Presentation(s):

• Paper 44 - COMBINATION OF MDM2 AND CDK4/6 INHIIBITOR IN PATIENTS WITH ADVANCED WELL AND DE-DIFFERENCIATED LIPOSARCOMA AND OTHERS CANCERS: COHORT ANALYSIS FROM THE MEGAMOST PHASE II BASKET STUDY

  Friday, November 15, 2024
  9:00 AM – 10:00 AM PST